Italian drug discovery specialist Axxam and German AI firm Molecular Health have struck a strategic alliance aimed at ...

US clinical-stage biotech Vigil Neuroscience (Nasdaq: VIGL) today announced a disappointing update on the Phase II IGNITE ...

Neuropsychiatric disorders specialist Alto Neuroscience, has entered into an asset purchase agreement with Chase Therapeutics ...

Danish dermatology specialist LEO Pharma has appointed Helle Hedegaard Juhl as executive vice president for global people and ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published the UK’s first official guidance to support the safe development and use of phage therapies - treatments that use ...

US clinical-stage biotech Sagimet Biosciences (Nasdaq: SGMT) today reported denifanstat met all primary and secondary ...

US biotech BioAge Labs (Nasdaq: BIOA) is expanding its obesity pipeline just months after shelving its lead drug in the ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

The American medicines regulator has committed to reviewing the safety of the abortion pill mifepristone, amid renewed ...

US pharma major Eli Lilly (NYSE: LLY) has struck a deal worth up to $870 million with Swedish biotech Camurus (Nasdaq ...

India’s Zydus Lifesciences (BOM:532321) announced that it has entered into a definitive agreement with Agenus (Nasdaq: AGEN) ...

The European Commission (EC) has approved Adcetris (brentuximab vedotin) in combination with etoposide, cyclophosphamide, ...